MedPath
HSA Approval

NYRIN TABLET 15 mg

SIN10357P

NYRIN TABLET 15 mg

NYRIN TABLET 15 mg

November 3, 1998

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

V03AF03

calcium folinate

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

LEUCOVORIN CALCIUM EQV LEUCOVORIN

15 mg

Leucovorin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NYRIN TABLET 15 mg - HSA Approval | MedPath